What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits

Medical Decision Making

Volumn 36, Issue 7, 2016, Pages 900-910

  Hunter, Wynn G ^a   Zhang, Cecilia Z ^a   Hesson, Ashley ^b   Davis, J Kelly ^c   Kirby, Christine ^c   Williamson, Lillie D ^c,d   Barnett, Jamison A ^e   Ubel, Peter A ^a,c,f  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e Verilogue Inc   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

cost of illness; health expenditures; medical decision making; out of pocket costs; patient physician communication

Indexed keywords

AMBULATORY CARE; COST CONTROL; DOCTOR PATIENT RELATION; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE COST; HUMAN; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT;

AMBULATORY CARE FACILITIES; COST SAVINGS; FINANCING, PERSONAL; HEALTH CARE COSTS; HUMANS; OFFICE VISITS; PHYSICIAN-PATIENT RELATIONS;

EID: 84985930533     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X15626384     Document Type: Conference Paper

References (51)

1. Richman IB, Brodie M,. A national study of burdensome health care costs among non-elderly Americans. BMC Health Serv Res. 2014; 14 (1): 435.
2. Cohen RA, Kirzinger WK,. Financial burden of medical care: a family perspective. NCHS Data Brief. 2014; 142: 1-8.
3. Pollitz K, Cox C, Lucia K, Keith K,. Medical debt among people with health insurance. 2014. http://kff.org/private-insurance/report/medical-debt-among-people-with-health-insurance/.
4. Dolan PL,. High-deductible impact. Balancing rising out-of- pocket costs and outcomes. Med Econ. 2014; 91 (9): 17-20.
5. Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL,. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014; 32 (4): 306-11.
6. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013; 18 (4): 381-90.
7. Harrold LR, Peterson D, Beard AJ, Gurwitz JH, Briesacher BA,. Time trends in medication use and expenditures in older patients with rheumatoid arthritis. Am J Med. 2012; 125 (9): 937.e9 -. e15.
8. Zafar SY, Abernethy AP,. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013; 27 (2): 80-1, 149.
9. Cook K, Dranove D, Sfekas A,. Does major illness cause financial catastrophe? Health Serv Res. 2010; 45 (2): 418-36.
10. Himmelstein DU, Thorne D, Warren E, Woolhandler S,. Medical bankruptcy in the United States, 2007: results of a national study. Am J Med. 2009; 122 (8): 741-6.
11. Osterberg L, Blaschke T,. Adherence to medication. N Engl J Med. 2005; 353 (5): 487-97.
12. Neugut AI, Subar M, Wilde ET, et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol. 2011; 29 (18): 2534-42.
13. Pollitz K, Cox C, Lucia K, Keith K,. Medical debt among people with health insurance. Kaiser Family Foundation. 2014. Available from: URL: https://kaiserfamilyfoundation.files.wordpress.com/2014/01/8537-medical-debt-among-people-with-health-insurance.pdf.
14. Beach MC, Asch DA, Jepson C, et al. Public response to cost- quality tradeoffs in clinical decisions. Med Decis Making. 2003; 23 (5): 369-78.
15. Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM,. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004; 292 (8): 952-60.
16. Alexander GC, Tseng C-W,. Six strategies to identify and assist patients burdened by out-of-pocket prescription costs. Cleve Clin J Med. 2004; 71 (5): 433-7.
17. Wong Y-N, Egleston BL, Sachdeva K, et al. Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting. Med Care. 2013; 51 (9): 838-45.
18. Brill S,. Bitter pill: why medical bills are killing us. Time. 2013.
19. Farrell KS, Finocchio LJ, Trivedi AN, Mehrotra A,. Does price transparency legislation allow the uninsured to shop for care? J Gen Intern Med. 2010; 25 (2): 110-4.
20. Alexander GC,. Patient-physician communication about out- of-pocket costs. JAMA. 2003; 290 (7): 953-8.
21. Schmittdiel JA, Steers N, Duru OK, et al. Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study. BMC Health Serv Res. 2010; 10 (1): 164.
22. Pham HH, Alexander GC, O'Malley AS,. Physician consideration of patients' out-of-pocket costs in making common clinical decisions. Arch Intern Med. 2007; 167 (7): 663-8.
23. Shrank WH,. Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs. Ann Pharmacother. 2006; 40 (9): 1534-40.
24. Riggs KR, Ubel PA,. Overcoming barriers to discussing out-of- pocket costs with patients. JAMA Intern Med. 2014; 174 (6): 849-50.
25. Ubel PA, Abernethy AP, Zafar SY,. Full disclosure-out-of- pocket costs as side effects. N Engl J Med. 2013; 369 (16): 1484-6.
26. Moriates C, Shah NT, Arora VM,. First, do no (financial) harm. JAMA. 2013; 310 (6): 577-8.
27. Zafar SY, Tulsky JA, Abernethy AP,. It's time to have 'the talk': cost communication and patient-centered care. Oncology (Williston Park). 2014; 28 (6): 479-80.
28. Hunter WG, Ubel PA,. The black box of out-of-pocket cost communication: a path toward illumination. Ann Am Thorac Soc. 2014; 11 (10): 1608-9.
29. Alexander GC, Casalino LP, Meltzer DO,. Patient-physician communication about out-of-pocket costs. JAMA. 2003; 290 (7): 953-8.
30. Bestvina CM, Zullig LL, Rushing C, et al. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014; 10 (3): 162-7.
31. Beard AJ, Sleath B, Blalock SJ, et al. Predictors of rheumatoid arthritis patient-physician communication about medication costs during visits to rheumatologists. Arthritis Care Res. 2010; 62 (5): 632-9.
32. Tarn DM, Paterniti DA, Heritage J, Hays RD, Kravitz RL, Wenger NS,. Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care. 2006; 12 (11): 657-64.
33. Dennehy EB, Robinson RL, Stephenson JJ, et al. Impact of non- remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study. Curr Med Res Opin. 2015; 31 (6): 1165-77.
34. Choi S, Hasche L, Nguyen D,. Effects of depression on the subsequent year's healthcare expenditures among older adults: two- year panel study. Psychiatr Q. 2015; 86 (2): 225-41.
35. Wolfe F, Michaud K,. Out-of-pocket expenses and their burden in patients with rheumatoid arthritis. Arthritis Rheum. 2009; 61 (11): 1563-70.
36. Bureau of the Census. Urban area criteria for the 2010 census. Fed Reg. 2011; 76 (164): 1-15. Available from: URL: http://www2.census.gov/geo/pdfs/reference/fedreg/fedregv76n164.pdf. Accessed 27 Nov 2015.
37. Pimsieur P, Hancock C, Furey P,. Speech rate and listening comprehension. In: Burt MK, Dulay HC, Finocchiaro MB, eds. Viewpoints on English as a Second Language. New York: Regents; 1977. p 265.
38. Tauroza S, Allison D,. Speech rates in British English. Appl Ling. 1990; 11 (1): 90-105.
39. Clopper CJ, Pearson ES,. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934; 26 (4): 404-13.
40. Association of American Medical Colleges, Center for Workforce Studies. 2012 Physician Specialty Databook. 2012. p 1-43. Available from: URL: https://www.aamc.org/download/313228/data/2012physicianspecialtydatabook.pdf.
41. Irwin B, Kimmick G, Altomare I, et al. Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist. 2014; 19 (11): 1135-40.
42. Alexander GC, Casalino LP, Tseng C-W, McFadden D, Meltzer DO,. Barriers to patient-physician communication about out-of- pocket costs. J Gen Intern Med. 2004; 19 (8): 856-60.
43. Starner CI, Alexander GC, Bowen K, Qiu Y, Wickersham PJ, Gleason PP,. Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums. Health Aff (Millwood). 2014; 33 (10): 1761-9.
44. Choudhry NK, Lee JL, Agnew-Blais J, Corcoran C, Shrank WH,. Drug company-sponsored patient assistance programs: a viable safety net? Health Aff (Millwood) 2009; 28 (3): 827-34.
45. Ross JS, Kesselheim AS,. Prescription-drug coupons-no such thing as a free lunch. N Engl J Med. 2013; 369 (13): 1188-9.
46. Don't get hooked on prescription-drug coupons. Consumer Reports. 2012. Available from: URL: http://www.consumerreports.org/cro/2012/03/don-t-get-hooked-on-prescription-drug-coupons/index.htm.
47. Felder TM, Palmer NR, Lal LS, Mullen PD,. What is the evidence for pharmaceutical patient assistance programs? A systematic review. J Health Care Poor Underserved. 2011; 22 (1): 24-49.
48. Pollack A,. Coupons for patients, but higher bills for insurers. New York Times. 2 2011. Available from: URL: http://www.nytimes.com/2011/01/02/business/02coupon.html.
49. Bullock AJ, Hofstatter EW, Yushak ML, Buss MK,. Understanding patients' attitudes toward communication about the cost of cancer care. J Oncol Pract. 2012; 8 (4): e50-8.
50. Tseng C-W, Dudley RA, Brook RH, et al. Elderly patients' preferences and experiences with providers in managing their drug costs. J Am Geriatr Soc. 2007; 55 (12): 1974-80.
51. Danis M, Sommers R, Logan J, et al. Exploring public attitudes towards approaches to discussing costs in the clinical encounter. J Gen Intern Med. 2014; 29 (1): 223-9.